Celgene Corporation (CELG): Today's Featured Health Care Winner

Celgene Corporation ( CELG) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.5%. By the end of trading, Celgene Corporation rose 52 cents (0.8%) to $67.34 on light volume. Throughout the day, two million shares of Celgene Corporation exchanged hands as compared to its average daily volume of 3.8 million shares. The stock ranged in a price between $66.35-$67.75 after having opened the day at $66.83 as compared to the previous trading day's close of $66.82. Other companies within the Health Care sector that increased today were: Somaxon Pharmaceuticals ( SOMX), up 61.5%, Supernus Pharmaceuticals ( SUPN), up 37%, ADVENTRX Pharmaceuticals ( ANX), up 19.1%, and Cormedix ( CRMD), up 17.3%.

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes various therapies to treat cancer and immune-inflammatory related diseases primarily in the United States and Europe. Celgene Corporation has a market cap of $28.75 billion and is part of the drugs industry. The company has a P/E ratio of 20.3, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year to date as of the close of trading on Tuesday. Currently there are 23 analysts that rate Celgene Corporation a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates Celgene Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front, Natural Alternatives International ( NAII), down 18.4%, StemCells ( STEM), down 17.2%, Anthera Pharmaceuticals ( ANTH), down 16.9%, and MEI Pharma ( MEIP), down 12.8%, were all losers within the health care sector with Edwards Life ( EW) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks